Upcoming Events
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.